BRIEF: InSilico jumps in Hong Kong trading debut
Shares of AI-driven drug discovery platform InSilico Medicine (3696.HK) opened up 45% at HK$35 in their Hong Kong trading debut on Tuesday, before paring the gains to close up 34.1%…
InSilico seeks IPO boost to get AI drugs over the line
The drug developer has raised around $400 million in seven rounds of financing. But after burning through cash, the company needs fresh capital to sustain its work on AI-assisted drugs…
RELATED ARTICLES
-
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
-
XtalPi scores landmark deal for AI drug discovery
2228.HK
-
BRIEF: Pateo jumps in Hong Kong trading debut
2889.HK
-
BRIEF: Hesai jumps in Hong Kong trading debut
2525.HKHSAI.US
-
BRIEF: JST jumps in Hong Kong trading debut
6687.HK
-
BRIEF: Able Digital jumps in Hong Kong trading debut
2687.HK
-
BRIEF: Medtide rises in Hong Kong trading debut
3880.HK
